Business
Wellgistics Health Annual Letter to Shareholders From the Office of the CEO March 2025
Dear Shareholders, TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last year, Wellgistics was a private company, weathering the pressures of a broken pharmaceutical supply chain plagued with waste, inefficiencies, and a lack of pricing transparency that has decimated independent pharmacies and other stakeholders in the healthcare ecosystem. Today, we are a public company listed on the Nasdaq exchange under our new parent com
About this update from Wellgistics Health, Inc.
[{"type":"image","alt":"Wellgistics Health, Inc.","displaySize":"","headline":null,"caption":"Wellgistics Health, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":37,"url":"https://media.zenfs.com/en/globenewswire.com/3756275c8f89bb335042b64c61726096"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/GD0D_DEMfS50Y9mV91T3bg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUyO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/3756275c8f89bb335042b64c61726096","width":300,"height":37}},"lazy":false},{"type":"text","content":"Dear Shareholders,","length":18,"tagName":"p"},{"type":"text","content":"TAMPA, FL, March 27, 2025 (GLOBE NEWSWIRE) -- Wellgistics Health, Inc. (NASDAQ: WGRX) (“Wellgistics Health”), This time last year, Wellgistics was a private company, weathering the pressures of a broken pharmaceutical supply chain plagued with waste, inefficiencies, and a lack of pricing transparency that has decimated independent pharmacies and other stakeholders in the healthcare ecosystem.","length":395,"tagName":"p"},{"type":"text","content":"Today, we are a public company listed on the Nasdaq exchange under our new parent company name, Wellgistics Health, Inc. (NASDAQ: WGRX), we have completed several acquisitions that broaden our service offerings, and we have a full year 2024 pro forma consolidated net sales (assuming our recent acquisitions had occurred as of January 1st, 2023) of $45.7 million, which is a 33% increase over the previous year, with a clear plan to scale our impact across healthcare.¹","length":469,"tagName":"p"},{"type":"text","content":"What We Built in 2024","length":21,"tagName":"p"},{"type":"text","content":"We built an AI-enhanced end-to-end prescription processing platform—Wellgistics Hub (formerly DelivMeds)—that eliminates the guesswork for patients and providers.","length":162,"tagName":"p"},{"type":"text","content":"When a provider writes a prescription—either in-office or via telehealth—our software checks the insurance, applies discounts when appropriate, and presents the patient with transparent out-of-pocket costs in real-time.","length":219,"tagName":"p"},{"type":"text","content":"If affordability is an issue, the patient can request a cheaper alternative through the Wellgistics Hub app—triggering a seamless feedback loop between doctor and patient before the prescription is finalized. This ...